These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 20231986)

  • 1. Hepatitis A: the costs and benefits of the disease prevention by vaccine, Paraná, Brazil.
    Zahdi MR; Maluf I; Maluf EM
    Braz J Infect Dis; 2009 Aug; 13(4):257-61. PubMed ID: 20231986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness analysis of universal childhood hepatitis A vaccination in Brazil: regional analyses according to the endemic context.
    Sartori AM; de Soárez PC; Novaes HM; Amaku M; de Azevedo RS; Moreira RC; Pereira LM; Ximenes RA; Martelli CM
    Vaccine; 2012 Dec; 30(52):7489-97. PubMed ID: 23107593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of childhood hepatitis A vaccination in Argentina: a second dose is warranted.
    Ellis A; Rüttimann RW; Jacobs RJ; Meyerhoff AS; Innis BL
    Rev Panam Salud Publica; 2007 Jun; 21(6):345-56. PubMed ID: 17761046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of hepatitis A vaccination in Indonesia.
    Suwantika AA; Beutels P; Postma MJ
    Hum Vaccin Immunother; 2014; 10(8):2342-9. PubMed ID: 25424941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional variation in the cost effectiveness of childhood hepatitis A immunization.
    Jacobs RJ; Greenberg DP; Koff RS; Saab S; Meyerhoff AS
    Pediatr Infect Dis J; 2003 Oct; 22(10):904-14. PubMed ID: 14551492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Universal vaccination of children against hepatitis A in Chile: a cost-effectiveness study.
    Quezada A; Baron-Papillon F; Coudeville L; Maggi L
    Rev Panam Salud Publica; 2008 May; 23(5):303-12. PubMed ID: 18510790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health economic assessment of universal immunization of toddlers against Hepatitis A Virus (HAV) in Mexico.
    Carlos F; Gómez JA; Anaya P; Romano-Mazzotti L
    Hum Vaccin Immunother; 2016; 12(1):52-63. PubMed ID: 26503702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Public Health Impact and Cost-Effectiveness of Hepatitis A Vaccination in the United States: A Disease Transmission Dynamic Modeling Approach.
    Dhankhar P; Nwankwo C; Pillsbury M; Lauschke A; Goveia MG; Acosta CJ; Elbasha EH
    Value Health; 2015 Jun; 18(4):358-67. PubMed ID: 26091589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing potential introduction of universal or targeted hepatitis A vaccination in the Netherlands.
    Suijkerbuijk AW; Lugnér AK; van Pelt W; Wallinga J; Verhoef LP; de Melker HE; de Wit GA
    Vaccine; 2012 Jul; 30(35):5199-205. PubMed ID: 22721900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cost-effectiveness of vaccinating chronic hepatitis C patients against hepatitis A.
    Jacobs RJ; Koff RS; Meyerhoff AS
    Am J Gastroenterol; 2002 Feb; 97(2):427-34. PubMed ID: 11866283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic evaluations of hepatitis A vaccination in middle-income countries.
    Suwantika AA; Yegenoglu S; Riewpaiboon A; Tu HA; Postma MJ
    Expert Rev Vaccines; 2013 Dec; 12(12):1479-94. PubMed ID: 24168129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of universal childhood hepatitis A vaccination in Chile.
    Valenzuela MT; Jacobs RJ; Arteaga O; Navarrete MS; Meyerhoff AS; Innis BL
    Vaccine; 2005 Jul; 23(32):4110-9. PubMed ID: 15964479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-benefit analysis of hepatitis a vaccination in Thailand.
    Teppakdee A; Tangwitoon A; Khemasuwan D; Tangdhanakanond K; Suramaethakul N; Sriratanaban J; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 2002 Mar; 33(1):118-27. PubMed ID: 12118439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization Against Hepatitis A in Migrant Children: Three Vaccination Strategies, A Retrospective Study.
    Fahrni O; Posfay-Barbe KM; Wagner N
    Pediatr Infect Dis J; 2020 Feb; 39(2):164-169. PubMed ID: 31929432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of routine childhood vaccination for hepatitis A in the United States.
    Rein DB; Hicks KA; Wirth KE; Billah K; Finelli L; Fiore AE; Hoerger TJ; Bell BP; Armstrong GL
    Pediatrics; 2007 Jan; 119(1):e12-21. PubMed ID: 17200237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effective analysis of hepatitis A vaccination in Kerala state, India.
    Gurav YK; Bagepally BS; Chitpim N; Sobhonslidsuk A; Gupte MD; Chaikledkaew U; Thakkinstian A; Thavorncharoensap M
    PLoS One; 2024; 19(6):e0306293. PubMed ID: 38935781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Public health impact and cost effectiveness of routine childhood vaccination for hepatitis a in Jordan: a dynamic model approach.
    Hayajneh WA; Daniels VJ; James CK; Kanıbir MN; Pilsbury M; Marks M; Goveia MG; Elbasha EH; Dasbach E; Acosta CJ
    BMC Infect Dis; 2018 Mar; 18(1):119. PubMed ID: 29514609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cost-utility analysis on universal childhood hepatitis A vaccination in regions with different anti-HAV prevalence rates of China].
    Pan XJ; Feng YM; Zhuang GH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Aug; 33(8):862-6. PubMed ID: 22967346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmaco-economic evaluation of targeted hepatitis A vaccination for children of ethnic minorities in Amsterdam (The Netherlands).
    Postma MJ; Bos JM; Beutels P; Schilthuis H; van den Hoek JA
    Vaccine; 2004 May; 22(15-16):1862-7. PubMed ID: 15121296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic analysis of the single-dose immunization strategy against hepatitis A in Argentina.
    Vizzotti C; Pippo T; Urueña A; Altuna J; Palópoli G; Hernández ML; Artola MF; Fernández H; Orellano P; Cañero-Velasco MC; Ciocca M; Ramonet M; Diosque M
    Vaccine; 2015 May; 33 Suppl 1():A227-32. PubMed ID: 25919166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.